Skip to main content

FDA Updates

Rituximab plus Chemotherapy FDA Approved for Several Pediatric Hematologic Malignancies

Keytruda Now Approved for the Adjuvant Treatment of Stage IIB/IIC Melanoma

Orencia First Drug FDA Approved for the Prevention of Acute Graft-versus-Host Disease

Kimmtrak, a Bispecific CD3 T-Cell Engager, First FDA-Approved Drug for Unresectable or Metastatic Uveal Melanoma

Cytalux, a Novel Imaging Agent, FDA Approved for Diagnosing Inoperable Ovarian Cancer Lesions

FDA Approved Fyarro for Malignant Perivascular Epithelioid-Cell Tumor

Oral Scemblix FDA Approved for Patients with Ph-Positive Chronic Myeloid Leukemia

Darzalex Faspro, Kyprolis, and Dexamethasone a New Combination FDA Approved for Multiple Myeloma

Keytruda Now FDA Approved for Adjuvant Treatment of Renal-Cell Carcinoma

Tecentriq First Immunotherapy FDA Approved for Adjuvant Treatment of Early-Stage Non–Small-Cell Lung Cancer

6
7
8
9
10
11
12

Page 9 of 33
Results 81 - 90 of 330